Literature DB >> 19649573

[What can addiction research contribute towards the understanding of obesity?].

F Kiefer1, M Grosshans.   

Abstract

Recent research suggests similarities between obesity and addictive disorders on both phenomenological and neurobiological levels. In particular neuro-endocrine and imaging studies have shown a close link between homeostatic regulation involved in appetite regulation and regulation of motivation and reward expectancy, which are of special impact for addictive disorders. Based on findings on the neurobiology of reinforcement processes and on the role of classical conditioning in addiction, new interventions for prevention and treatment were developed that offer the opportunity for transfer to the treatment of obesity. A first step may be testing psychotherapeutic and pharmacotherapeutic interventions, which primarily target motivational processes. The relevance of this topic for general psychiatry is reflected by the fact that including obesity in the psychiatric chapters of disease classification systems is currently being discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19649573     DOI: 10.1007/s00115-009-2743-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  63 in total

1.  Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments.

Authors:  V Bassareo; G Di Chiara
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

2.  Reduction of coronary heart disease risk factors in the German cardiovascular prevention study.

Authors:  H Hoffmeister; G B Mensink; H Stolzenberg; J Hoeltz; H Kreuter; U Laaser; E Nüssel; K D Hüllemann; J V Troschke
Journal:  Prev Med       Date:  1996 Mar-Apr       Impact factor: 4.018

3.  Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.

Authors:  M Weintraub; P R Sundaresan; M Madan; B Schuster; A Balder; L Lasagna; C Cox
Journal:  Clin Pharmacol Ther       Date:  1992-05       Impact factor: 6.875

4.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

5.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

Review 6.  Medical hazards of obesity.

Authors:  F X Pi-Sunyer
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

7.  Evidence of an association of leptin serum levels and craving in alcohol dependence.

Authors:  Thomas Hillemacher; Stefan Bleich; Helge Frieling; Anja Schanze; Julia Wilhelm; Wolfgang Sperling; Johannes Kornhuber; Thomas Kraus
Journal:  Psychoneuroendocrinology       Date:  2006-11-13       Impact factor: 4.905

8.  Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin.

Authors:  Ute Krügel; Thomas Schraft; Holger Kittner; Wieland Kiess; Peter Illes
Journal:  Eur J Pharmacol       Date:  2003-12-15       Impact factor: 4.432

9.  The principle of homeostasis in the hypothalamus-pituitary-adrenal system: new insight from positive feedback.

Authors:  A Peters; M Conrad; C Hubold; U Schweiger; B Fischer; H L Fehm
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-04-25       Impact factor: 3.619

10.  Binge eating disorder: response to naltrexone.

Authors:  M A Marrazzi; K M Markham; J Kinzie; E D Luby
Journal:  Int J Obes Relat Metab Disord       Date:  1995-02
View more
  2 in total

1.  [Functional MRI and neurophysiological aspects of obesity].

Authors:  A Sztrokay; E Gutyrchik; M Reiser; T Meindl
Journal:  Radiologe       Date:  2011-05       Impact factor: 0.635

2.  [Morbidly obese patients: psychopathology and eating disorders. Results of a preoperative evaluation].

Authors:  Johann F Kinzl; Christoph Maier; Angelika Bösch
Journal:  Neuropsychiatr       Date:  2012-11-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.